ESOT update on immunosuppressive substances in clinical development or use 1995.
The ESOT Council conducted an inquiry on new immunosuppressive substances in order to help keep members of ESOT informed. Thirty-one pharmaceutical companies were sent a questionnaire indicating whether they were developing new immunosuppressive substances/antibodies. Sixteen companies responded: 11 furnished information on 16 substances; 5 said that they were not developing any new immunosuppressive agents. Fifteen companies did not reply at all. The results of the first inquiry are reported here.
Thiel
G
G
Division of Nephrology, Kantonsspital Basel, Switzerland.
D004345:Drug Industry; D005060:Europe; D006801:Humans; D007166:Immunosuppressive Agents / Q000592:standards; D012955:Societies, Medical; D011795:Surveys and Questionnaires; D014181:Transplantation Immunology
D007166:Immunosuppressive Agents